Peter Křenek

894 total citations
66 papers, 713 citations indexed

About

Peter Křenek is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Peter Křenek has authored 66 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cardiology and Cardiovascular Medicine, 22 papers in Molecular Biology and 19 papers in Physiology. Recurrent topics in Peter Křenek's work include Nitric Oxide and Endothelin Effects (16 papers), Pulmonary Hypertension Research and Treatments (11 papers) and Renin-Angiotensin System Studies (10 papers). Peter Křenek is often cited by papers focused on Nitric Oxide and Endothelin Effects (16 papers), Pulmonary Hypertension Research and Treatments (11 papers) and Renin-Angiotensin System Studies (10 papers). Peter Křenek collaborates with scholars based in Slovakia, Czechia and Belgium. Peter Křenek's co-authors include Ján Klimas, Ján Kyselovič, Peter Ochodnický, Dana Kučerová, Jana Kmecova, F Kristek, Soňa Čačányiová, Peter Kružliak, Andrea Gažová and Maurice Wibo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Hypertension.

In The Last Decade

Peter Křenek

63 papers receiving 703 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Křenek Slovakia 15 285 223 115 97 82 66 713
Ján Klimas Slovakia 17 464 1.6× 319 1.4× 108 0.9× 97 1.0× 104 1.3× 81 979
Susana Vallejo Spain 20 258 0.9× 381 1.7× 244 2.1× 182 1.9× 54 0.7× 29 1.2k
Wencheng Di China 14 117 0.4× 372 1.7× 146 1.3× 63 0.6× 92 1.1× 22 931
Maayan Waldman Israel 15 271 1.0× 353 1.6× 230 2.0× 179 1.8× 59 0.7× 24 876
Priska Kaufmann Switzerland 13 151 0.5× 307 1.4× 94 0.8× 35 0.4× 35 0.4× 36 777
Erkan Tuncay Türkiye 20 365 1.3× 639 2.9× 183 1.6× 174 1.8× 76 0.9× 66 1.2k
Shingo Takahara Japan 15 266 0.9× 263 1.2× 194 1.7× 225 2.3× 31 0.4× 30 795
Paul Stamm Germany 13 152 0.5× 289 1.3× 218 1.9× 325 3.4× 51 0.6× 31 924
Chunquan Yu China 16 186 0.7× 221 1.0× 69 0.6× 169 1.7× 29 0.4× 56 700
Xue-Fen Pang China 11 102 0.4× 162 0.7× 69 0.6× 81 0.8× 48 0.6× 13 468

Countries citing papers authored by Peter Křenek

Since Specialization
Citations

This map shows the geographic impact of Peter Křenek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Křenek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Křenek more than expected).

Fields of papers citing papers by Peter Křenek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Křenek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Křenek. The network helps show where Peter Křenek may publish in the future.

Co-authorship network of co-authors of Peter Křenek

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Křenek. A scholar is included among the top collaborators of Peter Křenek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Křenek. Peter Křenek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Křenek, Peter, et al.. (2025). Combination of dapagliflozin and pioglitazone lacks superiority against monotherapy in streptozotocin-induced nephropathy. Scientific Reports. 15(1). 1464–1464. 1 indexed citations
2.
3.
Křenek, Peter, et al.. (2023). Pioglitazone Alters Ace/Ace 2 Balance to Favour Ace2 Independently Of Glycaemia Levels in Diabetic Rat Heart.. PubMed. 78(8). 122–127. 4 indexed citations
4.
5.
Horváth, Csaba, et al.. (2022). Analysis of necroptosis and its association with pyroptosis in organ damage in experimental pulmonary arterial hypertension. Journal of Cellular and Molecular Medicine. 26(9). 2633–2645. 20 indexed citations
6.
Křenek, Peter, et al.. (2021). Dapagliflozin elevates plasma high-density lipoprotein levels and influences visceral fat gene expression in streptozotocin-induced diabetes mellitus. Journal of Pharmacy and Pharmacology. 73(6). 778–784. 7 indexed citations
7.
Gonçalvesová, Eva, et al.. (2021). Hematocrit-Related Alterations of Circulating microRNA-21 Levels in Heart Failure Patients with Reduced Ejection Fraction: A Preliminary Study. Genetic Testing and Molecular Biomarkers. 25(4). 302–306. 3 indexed citations
8.
Křenek, Peter, et al.. (2020). Impact of improving eating habits and rosmarinic acid supplementation on rat vascular and neuronal system in the metabolic syndrome model. British Journal Of Nutrition. 125(7). 757–767. 3 indexed citations
9.
Křenek, Peter, et al.. (2019). Hepatocyte growth factor plays a particular role in progression of overall cardiac damage in experimental pulmonary hypertension. International Journal of Medical Sciences. 16(6). 854–863. 8 indexed citations
10.
Rocca, Giampiero La, Peter Kružliak, Mariusz Adamek, et al.. (2017). Downregulation of myogenic microRNAs in sub-chronic but not in sub-acute model of daunorubicin-induced cardiomyopathy. Molecular and Cellular Biochemistry. 432(1-2). 79–89. 9 indexed citations
11.
Klimas, Ján, et al.. (2015). Daunorubicine-induced downregulation of cardiac PPARs expression was prevented by ramipril. European Heart Journal. 36. 149–150. 1 indexed citations
12.
Máťuš, Marek, Dana Kučerová, Peter Kružliak, et al.. (2015). Upregulation of SERCA2a following short-term ACE inhibition (by enalaprilat) alters contractile performance and arrhythmogenicity of healthy myocardium in rat. Molecular and Cellular Biochemistry. 403(1-2). 199–208. 9 indexed citations
13.
Ochodnický, Peter, Ján Klimas, Peter Křenek, et al.. (2014). Pioglitazone, a PPARγ agonist, provides comparable protection to angiotensin converting enzyme inhibitor ramipril against adriamycin nephropathy in rat. European Journal of Pharmacology. 730. 51–60. 17 indexed citations
14.
Čačányiová, Soňa, et al.. (2014). Different vasoactive effects of chronic endothelial and neuronal NO-synthase inhibition in young Wistar rats. Journal of Physiology and Biochemistry. 70(3). 749–760. 6 indexed citations
15.
Křenek, Peter, Jana Kmecova, Dana Kučerová, et al.. (2009). Isoproterenol-Induced Heart Failure in the Rat is Associated with Nitric Oxide-Dependent Functional Alterations of Cardiac Function. European Journal of Heart Failure. 11(2). 140–146. 98 indexed citations
16.
Klimas, Ján, Jana Kmecova, Zuzana Kyseľová, et al.. (2009). Pycnogenol® improves left ventricular function in streptozotocin‐induced diabetic cardiomyopathy in rats. Phytotherapy Research. 24(7). 969–974. 15 indexed citations
17.
Čačányiová, Soňa, F Kristek, M Gerová, Peter Křenek, & Ján Klimas. (2009). Effect of chronic nNOS inhibition on blood pressure, vasoactivity, and arterial wall structure in Wistar rats. Nitric Oxide. 20(4). 304–310. 17 indexed citations
18.
19.
Kyselovič, Ján, Peter Křenek, Maurice Wibo, & Théophile Godfraind. (2001). Effects of amlodipine and lacidipine on cardiac remodelling and renin production in salt‐loaded stroke‐prone hypertensive rats. British Journal of Pharmacology. 134(7). 1516–1522. 23 indexed citations
20.
Křenek, Peter, Ján Kyselovič, Nicole Morel, Maurice Wibo, & Théophile Godfraind. (1999). Angiotensin-induced endothelin expression in isolated rat aorta, functional consequence and inhibition by calcium antagonist. British Journal of Pharmacology. 126. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ján Klimas Breakdown of academic impact, for papers by Susana Vallejo Breakdown of academic impact, for papers by Wencheng Di Breakdown of academic impact, for papers by Maayan Waldman Breakdown of academic impact, for papers by Priska Kaufmann Breakdown of academic impact, for papers by Erkan Tuncay Breakdown of academic impact, for papers by Shingo Takahara Breakdown of academic impact, for papers by Paul Stamm Breakdown of academic impact, for papers by Chunquan Yu Breakdown of academic impact, for papers by Xue-Fen Pang
Rankless by CCL
2026